ICON plc
Clinical research powered by healthcare intelligence, from molecule to medicine.
ICON is a world-leading clinical research organization providing outsourced services across the full clinical trial lifecycle, from early phase through commercialization, to pharmaceutical, biotechnology, and medical device companies. Headquartered in Dublin, Ireland.
Phases
Indications / Therapeutic Areas
Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Clinical Trial Services
- Clinical Imaging Core Lab
- Central Laboratory Services
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Pharmacovigilance & Drug Safety
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Flow Cytometry Services
- Bioanalysis
- Translational Research
- Biomarker Assays
- Immunogenicity Assays (ADA / NAb)
- Ligand-Binding Bioanalysis (Large Molecule)
- LC-MS Bioanalysis (Small Molecule)
- Cardiovascular & Metabolic Specialty Services
- CNS Specialty Services
- Oncology Specialty Services
- Immunology & Inflammation Services
- Companion Diagnostics Development
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
Modalities
Technical specifications & accreditations
About this organization
Overview
ICON plc is a global contract research organization (CRO) that provides comprehensive outsourced clinical research services to pharmaceutical, biotechnology, medical device, and government organizations. The company operates through full-service and strategic solutions (functional service provider) models, with capabilities spanning early phase through post-approval monitoring.
Service Lines
Clinical Operations & Trial Management
- Full-service clinical trial management and operations
- Site and patient solutions with focus on recruitment and retention
- In-home services and decentralized trial capabilities
- Patient-centric trial design and real-world data integration
Early Phase & Bioanalytical Solutions
- Early clinical development services
- Bioanalytical laboratory capabilities
- Cardiac safety solutions including ECG, event monitoring, Holter monitoring, ECHO, and MUGA studies
Specialty Laboratory Services
- Precision medicine program support across all drug development phases
- Central laboratory services
- Clinical imaging capabilities
Data, Biostatistics & Medical Writing
- Biostatistics and data management
- eClinical and data management solutions
- Medical writing services
- Regulatory affairs support
Market Access & Outcomes
- Pricing, market access, and reimbursement expertise
- Outcome measures identification and implementation
- Evidence-based patient-focused approaches
Technology & Innovation
- Orbis: multi-agent AI platform connecting expertise, data, and AI across the clinical trial lifecycle
- EngageAI: voice of customer feedback platform enhanced with AI
- Wearables and mobile device integration for patient engagement
Biotech-Specific Services
- Full-service outsourcing for biotech companies
- Due diligence and asset valuation support
- Flexible engagement models tailored to biotech needs
Organizational Structure
ICON operates through multiple service delivery models:
- Full Service: Multi-project teams delivering customized solutions
- Strategic Solutions (FSP): Dedicated resources embedded in client organizations
- Global Business Services: Corporate support functions
- Accellacare Site Network: Clinical trial site operations
The company maintains headquarters in Dublin, Ireland, with employees across 119 locations in 53 countries.
Locations
Headquarters
Dublin · Ireland
Belgium
Belgium · Belgium
Bulgaria
Bulgaria · Bulgaria
Germany
Germany · Germany
Hungary
Hungary · Hungary
Italy
Italy · Italy
Netherlands
Netherlands · Netherlands
Poland
Poland · Poland
Romania
Romania · Romania
Slovakia
Slovakia · Slovakia
South Africa
South Africa · South Africa
Spain
Spain · Spain
Türkiye
Türkiye · Türkiye
United Kingdom
United Kingdom · United Kingdom
Australia
Australia · Australia
China
China · China
India
India · India
Japan
Japan · Japan
Korea
Korea · Korea
Malaysia
Malaysia · Malaysia
Taiwan
Taiwan · Taiwan
Argentina
Argentina · Argentina
Brazil
Brazil · Brazil
Chile
Chile · Chile
Colombia
Colombia · Colombia
Mexico
Mexico · Mexico
Belgium
Belgium · Belgium
Bulgaria
Bulgaria · Bulgaria
Germany
Germany · Germany
Hungary
Hungary · Hungary
Italy
Italy · Italy
Netherlands
Netherlands · Netherlands
Poland
Poland · Poland
Romania
Romania · Romania
Slovakia
Slovakia · Slovakia
South Africa
South Africa · South Africa
Spain
Spain · Spain
Türkiye
Türkiye · Türkiye
United Kingdom
United Kingdom · United Kingdom
Australia
Australia · Australia
China
China · China
India
India · India
Japan
Japan · Japan
Korea
Korea · Korea
Malaysia
Malaysia · Malaysia
Taiwan
Taiwan · Taiwan
Argentina
Argentina · Argentina
Brazil
Brazil · Brazil
Chile
Chile · Chile
Colombia
Colombia · Colombia
Mexico
Mexico · Mexico
United States
United States · United States
Related companies
Similar profiles by shared services, phases, and indications.
IQVIA- Phase I Clinical Trials
- Phase II Clinical Trials
ICON- Phase I Clinical Trials
- Phase II Clinical Trials
PPD- Phase II Clinical Trials
- Phase III Clinical Trials
Medpace- Phase I Clinical Trials
- Phase II Clinical Trials
Fortrea- Phase I Clinical Trials
- Phase II Clinical Trials
Syneos Health- Phase I Clinical Trials
- Phase II Clinical Trials
Novotech- Phase I Clinical Trials
- Phase II Clinical Trials
Tigermed- Phase I Clinical Trials
- Phase II Clinical Trials
Submit a verified review for this organization.
Markdown mirror: /companies/iconplc.md